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This second volume in Springer’s Systems Biology series
focuses on the organisation of pancreatic insulin-
producing beta cells, with a particular focus on the
technological approaches deemed necessary to further
our understanding of beta cell physiology and the
pathogenesis of diabetes. The book is divided into five
parts, which deal with system biology, imaging and
sensors, genetics and proteomics, physiological, pharma-
ceutical and clinical applications, mathematical modelling
and numerical simulation. Together, these sections com-
prise 23 chapters, several of which are written by
internationally known experts and cover such diverse
themes as the development of beta cells, their structural,
genetic, biochemical and physiological organisation, and
their relevance to the cell and pharmacological therapy of
diabetes. In addition, a variety of state-of-the-art methods—
from magnetic resonance imaging to bioimpedance
spectroscopy—and algorithms for the modelling of
substructures and whole body integration of beta cell
functions are covered. An interesting feature of the book
is that a number of the chapters are introduced by
mathematical, physical and chemical considerations,
aimed to pave the way for a better understanding of
the basic scientific concepts that underlie the biological
and clinical observations. Sadly, the chapters contain
only a few illustrations, which are of variable quality,
and only two chapters contain details of links to online
files. The major merit of the book is its attempt to link
the many disciplines that have been applied, often in
too narrow a way, to address individual levels of beta
cell organisation and function. Indeed, a minimal
understanding of the limits and advantages of each of
these methods is required for a scientist to fruitfully
combine several methods in a comprehensive and
innovative multi-disciplinary approach. Such a multi-
disciplinary effort is certainly needed, as many questions
about beta cells remain unanswered, in spite of a
substantial and costly effort by a wealth of scientists,
each of whom has a unique, but possibly too narrow,
area of expertise. This new understanding may lead to a
paradigm shift, which is needed for better understanding
of the beta cell in the context of the ongoing diabetes
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epidemic and the lack of recent major innovations in the
treatments available for the disease. Specifically, a
multidisciplinary approach could foster a fruitful collab-
oration between the in silico research and the wealth of
experimental and clinical research. A major limitation of
this book is its aim to cover a broad spectrum of topics,
which may not satisfy the expert yet may still be
beyond many graduate and post-doctoral students, who
are the primary target market of the publication. This is
a minor criticism of this interesting book, which I warmly
recommend should be on the shelves of all research
laboratories involved in modern beta cell research.
2740
